China Feihe (HKG:6186) Full Year 2024 Results
Key Financial Results
- Revenue: CN¥20.7b (up 6.2% from FY 2023).
- Net income: CN¥3.57b (up 5.3% from FY 2023).
- Profit margin: 17% (in line with FY 2023).
- EPS: CN¥0.40 (up from CN¥0.37 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
China Feihe EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 12%.
The primary driver behind last 12 months revenue was the Dairy Products and Nutritional Supplements Products segment contributing a total revenue of CN¥20.6b (99% of total revenue). The largest operating expense was Sales & Marketing costs, amounting to CN¥7.18b (70% of total expenses). Explore how 6186's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Food industry in Hong Kong.
Performance of the Hong Kong Food industry.
The company's shares are down 7.4% from a week ago.
Risk Analysis
You still need to take note of risks, for example - China Feihe has 1 warning sign we think you should be aware of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.